Swine Reproductive and Respiratory Syndrome Vaccine Market Report – Research, Industry Analysis Reports and Market Demands

Global Swine Reproductive and Respiratory Syndrome Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Active Vaccine
- 1.3.3 Inactivated Vaccines
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Government Tender
- 1.4.3 Market Sales
1.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size & Forecast
- 1.5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (2019-2030)
- 1.5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price (2019-2030)

2 Manufacturers Profiles

3 Competitive Environment: Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturer

3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturer Market Share in 2023
- 3.4.3 Top 6 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturer Market Share in 2023
3.5 Swine Reproductive and Respiratory Syndrome Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Swine Reproductive and Respiratory Syndrome Vaccine Market: Region Footprint
- 3.5.2 Swine Reproductive and Respiratory Syndrome Vaccine Market: Company Product Type Footprint
- 3.5.3 Swine Reproductive and Respiratory Syndrome Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region
- 4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2019-2030)
- 4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2019-2030)
- 4.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Region (2019-2030)
4.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2019-2030)
4.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2019-2030)
4.5 South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2019-2030)
4.6 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2019-2030)

5 Market Segment by Type

5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type (2019-2030)
5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application

6.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application (2019-2030)
6.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Application (2019-2030)

7 North America

7.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
- 7.3.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2019-2030)
- 7.3.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

8.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
- 8.3.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

9.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

10.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
- 10.3.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2019-2030)
- 10.3.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

11.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

12.1 Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
12.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
12.3 Swine Reproductive and Respiratory Syndrome Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Swine Reproductive and Respiratory Syndrome Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Reproductive and Respiratory Syndrome Vaccine
13.3 Swine Reproductive and Respiratory Syndrome Vaccine Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Swine Reproductive and Respiratory Syndrome Vaccine Typical Distributors
14.3 Swine Reproductive and Respiratory Syndrome Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
According to our (Global Info Research) latest study, the global Swine Reproductive and Respiratory Syndrome Vaccine market size was valued at US$ 485 million in 2023 and is forecast to a readjusted size of USD 936 million by 2030 with a CAGR of 10.0% during review period.
Boehringer ingelheim is the company with the largest market share, about 25 percent.
This report is a detailed and comprehensive analysis for global Swine Reproductive and Respiratory Syndrome Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Swine Reproductive and Respiratory Syndrome Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Swine Reproductive and Respiratory Syndrome Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Swine Reproductive and Respiratory Syndrome Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Swine Reproductive and Respiratory Syndrome Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Reproductive and Respiratory Syndrome Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Swine Reproductive and Respiratory Syndrome Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ASCENT CORPORATION, Boehringer-Ingelheim, MSD Animal Health, SPAH, Ceva, Chengdu TECH-BANK Biological Products Co,.Ltd, ringpu, QILU ANIMAL HEALTH PRODUCTS CO.,LTD, DAHUANONG, CAVAC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Swine Reproductive and Respiratory Syndrome Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Active Vaccine
Inactivated Vaccines
Market segment by Application
Government Tender
Market Sales
Major players covered
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Swine Reproductive and Respiratory Syndrome Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, with price, sales quantity, revenue, and global market share of Swine Reproductive and Respiratory Syndrome Vaccine from 2019 to 2024.
Chapter 3, the Swine Reproductive and Respiratory Syndrome Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Reproductive and Respiratory Syndrome Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Swine Reproductive and Respiratory Syndrome Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Reproductive and Respiratory Syndrome Vaccine.
Chapter 14 and 15, to describe Swine Reproductive and Respiratory Syndrome Vaccine sales channel, distributors, customers, research findings and conclusion.

Buy now